3 Einträge gefunden

1. Efficacy and Safety of Vilobelimab (IFX-1), a Novel Monoclonal Anti-C5a Antibody, in Patients With Early Severe Sepsis or Septic Shock - A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase IIa Trial (SCIENS Study)

   1. Bauer, Michael
   2. Weyland, Andreas
   3. Marx, Gernot
   4. Bloos, Frank
   5. Weber, Stephan
   6. Weiler, Norbert
   7. Kluge, Stefan

   2021 - Forschungsinformationssystem des UKE - frei zugänglich
2. Effect of Sodium Selenite Administration and Procalcitonin-Guided Therapy on Mortality in Patients With Severe Sepsis or Septic Shock: A Randomized Clinical Trial

   1. Bloos, Frank
   2. Trips, Evelyn
   3. Nierhaus, Axel
   4. Briegel, Josef
   5. Heyland, Daren K
   6. Jaschinski, Ulrich
   7. Moerer, Onnen

   2016 - Forschungsinformationssystem des UKE
3. Effect of empirical treatment with moxifloxacin and meropenem vs meropenem on sepsis-related organ dysfunction in patients with severe sepsis: a randomized trial.

   1. Brunkhorst, Frank M
   2. Oppert, Michael
   3. Marx, Gernot
   4. Bloos, Frank
   5. Ludewig, Katrin
   6. Putensen, Christian
   7. Nierhaus, Axel

   2012 - Forschungsinformationssystem des UKE